ArticleFrontiers in immunology2025

Real-world study of adebrelimab as first-line therapy for extensive-stage small cell lung cancer: a retrospective study.

Kaili Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.